Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on May 24, 2019 8:56am
111 Views
Post# 29770489

RE:RE:RE:RE:My final take on this hot mess

RE:RE:RE:RE:My final take on this hot mess
The only evidence we have seems to point in that direction. The rapid approval by the TSX with little serious due diligence and approval of the hardship application over the many unchecked complaints of major fraud as to the existence of any hardship needed by the regulation to bypass a shareholders vote. Done by the collusion of those handful officers who presented this application to the TSX "on behalf of" PLI but clearly against the interest of the shareholders many of whom would llose the life savings and retirement savings!!!
Bullboard Posts